# reload+after+2024-01-21 16:43:27.959114
address1§3 Temasek Avenue
address2§Level 18 Centennial Tower
city§Singapore
zip§039190
country§Singapore
phone§65 6817 9598
website§https://aslanpharma.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal antibody that targets the IL-13 receptor a1 subunit which is being developed for the treatment of atopic dermatitis and other immunology indications; and ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase for the treatment of autoimmune diseases. It has a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd. to develop immuno-oncology therapeutics for markets targeting the AhR pathway. Its partners include Almirall, Array BioPharma, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore.
fullTimeEmployees§34
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Carl Alan Jason Morton Firth EMBA, Ph.D.', 'age': 50, 'title': 'Founder, CEO & Executive Director', 'yearBorn': 1973, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Kiran Kumar  Asarpota', 'age': 44, 'title': 'COO & Head of Finance', 'yearBorn': 1979, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Ben  Goodger', 'age': 60, 'title': 'General Counsel', 'yearBorn': 1963, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Stephen  Doyle', 'age': 50, 'title': 'Chief Business Officer', 'yearBorn': 1973, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Alexandre  Kaoukhov M.D.', 'age': 49, 'title': 'Chief Medical Officer', 'yearBorn': 1974, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Charlie  Hsu', 'title': 'Investor Relations Director', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Chi-Chin  Wang', 'title': 'IR & Corporate Development Director', 'exercisedValue': 0, 'unexercisedValue': 0}]
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.369
priceToSalesTrailing12Months§0.6612035
currency§USD
dateShortInterest§1702598400
forwardEps§-4.25
exchange§NCM
quoteType§EQUITY
shortName§ASLAN Pharmaceuticals Limited
longName§ASLAN Pharmaceuticals Limited
firstTradeDateEpochUtc§1525440600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§64d5d950-3f7f-30f1-9c3d-4a28bad97a03
gmtOffSetMilliseconds§-18000000
targetHighPrice§17.0
targetLowPrice§15.0
targetMeanPrice§16.0
targetMedianPrice§16.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§2
quickRatio§1.946
grossMargins§1.0
ebitdaMargins§0.0
trailingPegRatio§None
